Zealand Pharma AS (ZLDPF)
135.65
+2.24
(+1.68%)
USD |
OTCM |
Sep 20, 16:00
Zealand Pharma Market Cap: 9.622B for Sept. 20, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| September 20, 2024 | 9.622B |
| September 19, 2024 | 9.464B |
| September 18, 2024 | 9.464B |
| September 17, 2024 | 9.556B |
| September 16, 2024 | 9.556B |
| September 13, 2024 | 9.701B |
| September 12, 2024 | 9.279B |
| September 11, 2024 | 9.363B |
| September 10, 2024 | 8.920B |
| September 09, 2024 | 8.867B |
| September 06, 2024 | 8.975B |
| September 05, 2024 | 8.802B |
| September 04, 2024 | 9.080B |
| September 03, 2024 | 8.938B |
| August 30, 2024 | 8.938B |
| August 29, 2024 | 8.938B |
| August 28, 2024 | 8.938B |
| August 27, 2024 | 9.044B |
| August 26, 2024 | 9.044B |
| August 23, 2024 | 9.273B |
| August 22, 2024 | 9.381B |
| August 21, 2024 | 9.456B |
| August 20, 2024 | 9.395B |
| August 19, 2024 | 9.546B |
| August 16, 2024 | 10.05B |
| Date | Value |
|---|---|
| August 15, 2024 | 9.716B |
| August 14, 2024 | 9.716B |
| August 13, 2024 | 9.433B |
| August 12, 2024 | 8.917B |
| August 09, 2024 | 9.241B |
| August 08, 2024 | 8.957B |
| August 07, 2024 | 8.936B |
| August 06, 2024 | 8.801B |
| August 05, 2024 | 8.409B |
| August 02, 2024 | 9.319B |
| August 01, 2024 | 9.319B |
| July 31, 2024 | 9.433B |
| July 30, 2024 | 9.386B |
| July 29, 2024 | 8.942B |
| July 26, 2024 | 9.166B |
| July 25, 2024 | 9.621B |
| July 24, 2024 | 9.219B |
| July 23, 2024 | 9.139B |
| July 22, 2024 | 8.999B |
| July 19, 2024 | 8.936B |
| July 18, 2024 | 8.857B |
| July 17, 2024 | 8.936B |
| July 16, 2024 | 9.667B |
| July 15, 2024 | 9.611B |
| July 12, 2024 | 9.575B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
481.42M
Minimum
May 11 2022
10.05B
Maximum
Aug 16 2024
2.288B
Average
1.425B
Median
Feb 02 2021
Market Cap Benchmarks
| Novo Nordisk AS | 567.60B |
| Eli Lilly and Co | 829.73B |
| Altimmune Inc | 553.64M |
| Genmab AS | 16.21B |
| Viking Therapeutics Inc | 7.816B |
Market Cap Related Metrics
| PS Ratio | 153.63 |
| Price to Book Value | 7.134 |
| Price | 135.65 |
| Earnings Yield | -1.25% |